INTRODUCTION Melasma is a term derived from the Greek word “ melas†meaning black. Melasma is an acquired light or dark brown hyperpigmentation that commonly occurs on the sun exposed…
Read More
INTRODUCTION Valrubicin (N-trifluoroacetyladriamycin-14-valerate) is a semisynthetic anthracycline originally developed from doxorubicin as an anti-cancer drug and currently approved as Valstarâ„¢ (Endo Pharmaceuticals, Lexington, MA) for the treatment of bladder cancer.1,2…
Read More
INTRODUCTION Acne is a very common condition that has been reported to affect as many as 80% of adolescents and young adults. The incidence of acne scarring in the general…
Read More
INTRODUCTION Etanercept (Enbrel) is a fusion protein, which is FDA-approved for treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, moderate to severe plaque psoriasis in adults over…
Read More
INTRODUCTION A short-pulsed Er:YAG laser emits 2940-nm energy which is absorbed 12 to 18 times more efficiently by superficial aqueous tissue than the 10,600-nm energy of the CO2 laser.1 Tissue…
Read More
INTRODUCTION Marine gorgonian organisms are a prolific source of novel biologically active products called the pseudopterosins, which exhibit a range of biomedical activities. For decades, extensive research on the psedopterosins…
Read More
INTRODUCTION Injections with filler agents are becoming increasingly popular as a treatment for wrinkles and for soft tissue augmentation. While there are many options for use with fillers, hyaluronic acid…
Read More
The goal of residency program at New York Presbyterian Hospital-Weill Cornell Medical Center is to train physicians to be world-class providers of dermatologic care with the highest ethical standards and…
Read More
Beyond Eyelash Lengthening:Prostaglandin Analogues for Scalp and EyebrowsScalp alopecias continue to be a challenge to clinicians and cause a major impact on a person's quality of life. Treatment options are…
Read More
FDA Approves VALCHLOR Ceptaris Therapeutics, Inc., has announced that the FDA has granted marketing approval for the orphan drug VALCHLORTM (mechlorethamine) gel for the topical treatment of stage IA and…
Read More
An Open Label Study Employing the Topical Immunomodulator Diphenylcyclopropenone in a Stabilized Gel to Treat Cutaneous Metastases Sponsored by Rockefeller University, This is an open label study to determine the…
Read More
INTRODUCTION Skin cancer is the most common form of cancer worldwide. Basal cell carcinoma (BCC) is the most common type of skin cancer,1,2 with an estimated 1.3 to 1.5 million…
Read More






